TARYN LYZ GO
Prescription History 1326691221
Pharmacist in Arcadia, CA

NPI Status: Active since July 19, 2019

Contact Information

1343 OAKWOOD DR
ARCADIA, CA
ZIP 91006
Phone: (626) 664-0924

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for TARYN LYZ GO, an active Pharmacist specialist practicing in Arcadia, CA. Our medical registry currently tracks 34 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 3,308 documented patient claims. Among these therapy options, the most frequently utilized medication is Atorvastatin Calcium, which accounts for 564 claims alone.


Atorvastatin Calcium

Generic Formulation: Atorvastatin CalciumSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 564
30-Day Fills 1,870.3
Days Supply 56,142
CA State Average Benchmarks
Peer Average Claims194.0
Peer Average 30-Day Fills503.5
Peer Average Days Supply14,987
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 190.7% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,500.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.85

State Avg Cost Per Claim

$14.16

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrole and heptanoic acid derivative, HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITOR (statin), and ANTICHOLESTEREMIC AGENT that is used to reduce serum levels of LDL-CHOLESTEROL; APOLIPOPROTEIN B; and TRIGLYCERIDES. It is used to increase serum levels of HDL-CHOLESTEROL in the treatment of HYPERLIPIDEMIAS, and for the prevention of CARDIOVASCULAR DISEASES in patients with multiple risk factors.

Therapeutic Applications

Atorvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Glimepiride

Generic Formulation: GlimepirideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 12
30-Day Fills 37.6
Days Supply 1,130
CA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills96.2
Peer Average Days Supply2,866
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 70.7% less volume than the regional standard for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $168.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.06

State Avg Cost Per Claim

$14.61

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Alkaloids derived from TYRAMINE combined with 3,4-dihydroxybenzaldehyde via a norbelladine pathway, including GALANTAMINE, lycorine and crinine. They are found in the AMARYLLIDACEAE plant family.

Therapeutic Applications

Glimepiride is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glimepiride belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide

Generic Formulation: GlipizideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 191
30-Day Fills 624.4
Days Supply 18,700
CA State Average Benchmarks
Peer Average Claims49.0
Peer Average 30-Day Fills129.5
Peer Average Days Supply3,855
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 289.8% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,428.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.71

State Avg Cost Per Claim

$11.73

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Glipizide Er

Generic Formulation: GlipizideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 90
30-Day Fills 288.7
Days Supply 8,670
CA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills74.1
Peer Average Days Supply2,213
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 221.4% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,064.47 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.05

State Avg Cost Per Claim

$24.51

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Humalog

Generic Formulation: Insulin LisproSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 25
30-Day Fills 72.9
Days Supply 2,187
CA State Average Benchmarks
Peer Average Claims24.0
Peer Average 30-Day Fills45.4
Peer Average Days Supply1,276
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,463.21 across this reporting matrix range.

Provider Avg Cost Per Claim

$338.53

State Avg Cost Per Claim

$666.36

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humalog Kwikpen U-100

Generic Formulation: Insulin LisproSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 44
30-Day Fills 106.9
Days Supply 3,205
CA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills54.0
Peer Average Days Supply1,550
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 63.0% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,276.15 across this reporting matrix range.

Provider Avg Cost Per Claim

$369.91

State Avg Cost Per Claim

$774.99

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES.

Therapeutic Applications

Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide).

Humulin 70-30

Generic Formulation: Insulin Nph Hum/Reg Insulin HmSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 35
30-Day Fills 108.9
Days Supply 3,265
CA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills49.0
Peer Average Days Supply1,433
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 59.1% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,835.78 across this reporting matrix range.

Provider Avg Cost Per Claim

$309.59

State Avg Cost Per Claim

$381.00

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Humulin 70/30 Kwikpen

Generic Formulation: Insulin Nph Hum/Reg Insulin HmSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 32
30-Day Fills 86.1
Days Supply 2,581
CA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills50.0
Peer Average Days Supply1,455
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 39.1% more claims than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $10,633.70 across this reporting matrix range.

Provider Avg Cost Per Claim

$332.30

State Avg Cost Per Claim

$505.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Humulin N

Generic Formulation: Insulin Nph Human IsophaneSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 103
30-Day Fills 306.0
Days Supply 9,179
CA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills93.1
Peer Average Days Supply2,764
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 194.3% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $17,170.34 across this reporting matrix range.

Provider Avg Cost Per Claim

$166.70

State Avg Cost Per Claim

$185.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Humulin N Kwikpen

Generic Formulation: Insulin Nph Human IsophaneSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 98
30-Day Fills 261.2
Days Supply 7,837
CA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills64.8
Peer Average Days Supply1,919
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 263.0% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $21,437.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$218.75

State Avg Cost Per Claim

$226.14

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Humulin R

Generic Formulation: Insulin Regular, HumanSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 45
30-Day Fills 131.5
Days Supply 3,943
CA State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills56.8
Peer Average Days Supply1,577
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 66.7% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,581.96 across this reporting matrix range.

Provider Avg Cost Per Claim

$168.49

State Avg Cost Per Claim

$140.59

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Inhaled insulin powder is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. This man-made insulin product is the same as human insulin. It replaces the insulin that your body would normally make. It is a short-acting insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This product is absorbed into the blood through your lungs. It starts working faster and lasts for a shorter time than regular insulin injected under the skin. It is usually used in combination with a medium- or long-acting insulin product. This medication may also be used alone or with other oral diabetes drugs (such as metformin).

Insulin Glargine-Yfgn

Generic Formulation: Insulin Glargine-YfgnSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 41
30-Day Fills 110.5
Days Supply 3,306
CA State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills31.2
Peer Average Days Supply613
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 41.4% more claims than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,678.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$138.49

State Avg Cost Per Claim

$71.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Jardiance

Generic Formulation: EmpagliflozinSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 199
30-Day Fills 576.1
Days Supply 17,270
CA State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills89.0
Peer Average Days Supply2,645
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 342.2% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $170,837.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$858.48

State Avg Cost Per Claim

$1,009.41

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure. It may help you live longer and lower your risk of going to the hospital for heart failure. Empagliflozin works by increasing the removal of sodium by your kidneys.

Lantus

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 40
30-Day Fills 111.6
Days Supply 3,345
CA State Average Benchmarks
Peer Average Claims22.0
Peer Average 30-Day Fills37.1
Peer Average Days Supply1,060
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 81.8% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,243.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$231.09

State Avg Cost Per Claim

$536.43

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 16
30-Day Fills 40.6
Days Supply 1,215
CA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills64.3
Peer Average Days Supply1,855
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 54.3% less volume than the regional standard for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,959.20 across this reporting matrix range.

Provider Avg Cost Per Claim

$247.45

State Avg Cost Per Claim

$541.78

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Lisinopril

Generic Formulation: LisinoprilSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 210
30-Day Fills 691.3
Days Supply 20,760
CA State Average Benchmarks
Peer Average Claims100.0
Peer Average 30-Day Fills262.9
Peer Average Days Supply7,834
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 110.0% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,658.14 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.66

State Avg Cost Per Claim

$9.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

One of the ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACE inhibitors), orally active, that has been used in the treatment of hypertension and congestive heart failure.

Therapeutic Applications

Lisinopril is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat heart failure and to improve survival after a heart attack. Lisinopril belongs to a class of drugs known as ACE inhibitors. It works by relaxing blood vessels so blood can flow more easily.

Lisinopril-Hydrochlorothiazide

Generic Formulation: Lisinopril/HydrochlorothiazideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 73
30-Day Fills 240.8
Days Supply 7,230
CA State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills119.2
Peer Average Days Supply3,570
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 82.5% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $947.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.98

State Avg Cost Per Claim

$11.84

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: lisinopril and hydrochlorothiazide. Lisinopril is an ACE inhibitor and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a water pill (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water. This product is used when one drug is not controlling your blood pressure. Your doctor may direct you to take the individual medications first, and then switch you to this combination product. Do not continue taking the individual medications (lisinopril and/or hydrochlorothiazide) after you start this medication.

Losartan Potassium

Generic Formulation: Losartan PotassiumSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 168
30-Day Fills 556.1
Days Supply 16,700
CA State Average Benchmarks
Peer Average Claims116.0
Peer Average 30-Day Fills302.4
Peer Average Days Supply9,023
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 44.8% more claims than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,158.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.85

State Avg Cost Per Claim

$13.35

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.

Therapeutic Applications

Losartan is used to treat high blood pressure (hypertension) and to help protect the kidneys from damage due to diabetes. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Losartan belongs to a class of drugs called angiotensin receptor blockers (ARBs). It works by relaxing blood vessels so that blood can flow more easily.

Losartan-Hydrochlorothiazide

Generic Formulation: Losartan/HydrochlorothiazideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 12
30-Day Fills 40.0
Days Supply 1,200
CA State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills99.3
Peer Average Days Supply2,973
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 67.6% less volume than the regional standard for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $133.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.11

State Avg Cost Per Claim

$25.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This drug is used to treat high blood pressure. It is also used to lower the risk of strokes in patients with high blood pressure and an enlarged heart. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. This product contains two medications: losartan and hydrochlorothiazide. Losartan is an angiotensin receptor blocker (ARB) and works by relaxing blood vessels so that blood can flow more easily. Hydrochlorothiazide is a water pill (diuretic) that causes you to make more urine, which helps your body get rid of extra salt and water.

Lovastatin

Generic Formulation: LovastatinSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 23
30-Day Fills 74.3
Days Supply 2,230
CA State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills92.5
Peer Average Days Supply2,765
Conservative Utilization

This provider writes prescriptions for this formulation 30.3% less frequently than the standard regional baseline metric for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $263.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.47

State Avg Cost Per Claim

$13.18

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fungal metabolite isolated from cultures of Aspergillus terreus. The compound is a potent anticholesteremic agent. It inhibits 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It also stimulates the production of low-density lipoprotein receptors in the liver.

Therapeutic Applications

Lovastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Metformin Hcl

Generic Formulation: Metformin HclSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 272
30-Day Fills 889.8
Days Supply 26,720
CA State Average Benchmarks
Peer Average Claims101.0
Peer Average 30-Day Fills250.5
Peer Average Days Supply7,453
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 169.3% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,726.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$13.70

State Avg Cost Per Claim

$10.07

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Metformin Hcl Er

Generic Formulation: Metformin HclSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 408
30-Day Fills 1,319.4
Days Supply 39,538
CA State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills132.1
Peer Average Days Supply3,949
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 750.0% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,053.22 across this reporting matrix range.

Provider Avg Cost Per Claim

$9.93

State Avg Cost Per Claim

$11.67

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)

Therapeutic Applications

Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb.

Ozempic

Generic Formulation: SemaglutideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 66
30-Day Fills 78.5
Days Supply 2,228
CA State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills62.6
Peer Average Days Supply1,823
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 53.5% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $57,143.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$865.82

State Avg Cost Per Claim

$1,314.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment.

Pioglitazone Hcl

Generic Formulation: Pioglitazone HclSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 37
30-Day Fills 113.6
Days Supply 3,394
CA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills101.5
Peer Average Days Supply3,027
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $849.33 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.95

State Avg Cost Per Claim

$23.89

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Pioglitazone is a diabetes drug (thiazolidinedione-type, also called glitazones) used along with a proper diet and exercise program to control high blood sugar in patients with type 2 diabetes. It works by helping to restore your body's proper response to insulin, thereby lowering your blood sugar. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Pioglitazone is used either alone or in combination with other diabetes medications (such as metformin or a sulfonylurea such as glyburide). Talk to your doctor about the risks and benefits of pioglitazone.

Pravastatin Sodium

Generic Formulation: Pravastatin SodiumSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 17
30-Day Fills 56.6
Days Supply 1,700
CA State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills102.7
Peer Average Days Supply3,064
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 56.4% less volume than the regional standard for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $508.35 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.90

State Avg Cost Per Claim

$19.88

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An antilipemic fungal metabolite isolated from cultures of Nocardia autotrophica. It acts as a competitive inhibitor of HMG CoA reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES).

Therapeutic Applications

Pravastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Rosuvastatin Calcium

Generic Formulation: Rosuvastatin CalciumSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 43
30-Day Fills 143.2
Days Supply 4,300
CA State Average Benchmarks
Peer Average Claims86.0
Peer Average 30-Day Fills222.9
Peer Average Days Supply6,667
Conservative Utilization

This provider writes prescriptions for this formulation 50.0% less frequently than the standard regional baseline metric for practitioners inside CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $687.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$16.00

State Avg Cost Per Claim

$35.52

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A HYDROXYMETHYLGLUTARYL-COA-REDUCTASE INHIBITOR, or statin, that reduces the plasma concentrations of LDL-CHOLESTEROL; APOLIPOPROTEIN B, and TRIGLYCERIDES while increasing HDL-CHOLESTEROL levels in patients with HYPERCHOLESTEROLEMIA and those at risk for CARDIOVASCULAR DISEASES.

Therapeutic Applications

Rosuvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps to prevent strokes and heart attacks. In addition to eating a proper diet (such as a low cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Talk with your doctor for more details.

Simvastatin

Generic Formulation: SimvastatinSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 80
30-Day Fills 264.1
Days Supply 7,927
CA State Average Benchmarks
Peer Average Claims72.0
Peer Average 30-Day Fills193.4
Peer Average Days Supply5,770
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $925.40 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.57

State Avg Cost Per Claim

$10.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A derivative of LOVASTATIN and potent competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HYDROXYMETHYLGLUTARYL COA REDUCTASES), which is the rate-limiting enzyme in cholesterol biosynthesis. It may also interfere with steroid hormone production. Due to the induction of hepatic LDL RECEPTORS, it increases breakdown of LDL CHOLESTEROL.

Therapeutic Applications

Simvastatin is used along with a proper diet to help lower bad cholesterol and fats (such as LDL, triglycerides) and raise good cholesterol (HDL) in the blood. It belongs to a group of drugs known as statins. It works by reducing the amount of cholesterol made by the liver. Lowering bad cholesterol and triglycerides and raising good cholesterol decreases the risk of heart disease and helps prevent strokes and heart attacks. In addition to eating a proper diet (such as a low-cholesterol/low-fat diet), other lifestyle changes that may help this medication work better include exercising, losing weight if overweight, and stopping smoking. Consult your doctor for more details.

Ultra-Fine Mini Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 55
30-Day Fills 170.5
Days Supply 5,120
CA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills45.6
Peer Average Days Supply1,349
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 161.9% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,730.30 across this reporting matrix range.

Provider Avg Cost Per Claim

$31.46

State Avg Cost Per Claim

$73.10

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Ultra-Fine Nano Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 87
30-Day Fills 256.6
Days Supply 7,706
CA State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills53.8
Peer Average Days Supply1,600
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 278.3% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,641.05 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.36

State Avg Cost Per Claim

$61.01

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Veo Insulin Syringe

Generic Formulation: Syringe-Needle,insulin,0.5 MlSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 74
30-Day Fills 231.1
Days Supply 6,940
CA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills42.0
Peer Average Days Supply1,258
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 335.3% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,764.07 across this reporting matrix range.

Provider Avg Cost Per Claim

$23.84

State Avg Cost Per Claim

$22.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Veo Insulin Syringe

Generic Formulation: Syringe And Needle,insulin,1mlSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 32
30-Day Fills 105.2
Days Supply 3,160
CA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills42.0
Peer Average Days Supply1,258
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 88.2% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $936.50 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.27

State Avg Cost Per Claim

$22.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Veo Insulin Syringe

Generic Formulation: Syrge-Ndl,ins 0.3 Ml Half MarkSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 22
30-Day Fills 50.0
Days Supply 1,500
CA State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills42.0
Peer Average Days Supply1,258
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 29.4% more claims than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $540.43 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.57

State Avg Cost Per Claim

$22.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Victoza 2-Pak

Generic Formulation: LiraglutideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 73
30-Day Fills 111.8
Days Supply 3,295
CA State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills27.2
Peer Average Days Supply791
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 284.2% higher than the standard regional baseline profile for CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $72,283.46 across this reporting matrix range.

Provider Avg Cost Per Claim

$990.18

State Avg Cost Per Claim

$990.86

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Victoza 3-Pak

Generic Formulation: LiraglutideSpecialty: Pharmacist
Provider Metrics Summary
Total Claims 21
30-Day Fills 49.0
Days Supply 1,470
CA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills33.6
Peer Average Days Supply995
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across CA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $35,961.00 across this reporting matrix range.

Provider Avg Cost Per Claim

$1,712.43

State Avg Cost Per Claim

$1,586.65

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

Therapeutic Applications

This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like TARYN LYZ GO provides transparency into local medical care patterns within Arcadia, CA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Pharmacist** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.